DOCSLIB.ORG

Addendum A: Antiparasitic Drugs Used for Animals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Addendum A: Antiparasitic Drugs Used for Animals Addendum A: Antiparasitic Drugs Used for Animals Each product can only be used according to dosages and descriptions given on the leaflet within each package. Table A.1 Selection of drugs against protozoan diseases of dogs and cats (these compounds are not approved in all countries but are often available by import) Dosage (mg/kg Parasites Active compound body weight) Application Isospora species Toltrazuril D: 10.00 1Â per day for 4–5 d; p.o. Toxoplasma gondii Clindamycin D: 12.5 Every 12 h for 2–4 (acute infection) C: 12.5–25 weeks; o. Every 12 h for 2–4 weeks; o. Neospora Clindamycin D: 12.5 2Â per d for 4–8 sp. (systemic + Sulfadiazine/ weeks; o. infection) Trimethoprim Giardia species Fenbendazol D/C: 50.0 1Â per day for 3–5 days; o. Babesia species Imidocarb D: 3–6 Possibly repeat after 12–24 h; s.c. Leishmania species Allopurinol D: 20.0 1Â per day for months up to years; o. Hepatozoon species Imidocarb (I) D: 5.0 (I) + 5.0 (I) 2Â in intervals of + Doxycycline (D) (D) 2 weeks; s.c. plus (D) 2Â per day on 7 days; o. C cat, D dog, d day, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.2 Selection of drugs against nematodes of dogs and cats (unfortunately not effective against a broad spectrum of parasites) Active compounds Trade names Dosage (mg/kg body weight) Application ® Fenbendazole Panacur D: 50.0 for 3 d o. C: 50.0 for 3 d Flubendazole Flubenol® D: 22.0 for 3 d o. C: 22.0 for 3 d (continued) # Springer International Publishing Switzerland 2016 663 H. Mehlhorn, Animal Parasites, DOI 10.1007/978-3-319-46403-9 664 Addendum A: Antiparasitic Drugs Used for Animals Table A.2 (continued) Active compounds Trade names Dosage (mg/kg body weight) Application Mebendazole Telmin® KH D/C:2Â/d 50–100 mg/5 d o. Selamectin Stronghold® D/C: 6.0 Spot on Epsiprantel Cestex® D: 5.5 o. C: 2.75 Nitroscanate Lopatol®, Excanat® D: 50.0 o. Pyrantelpamoate Banminth® D: 5.0 o. C: 20.0 Pyrantel + Febantel Welpan® D: 5.0 (B) + 15.0 o. Nitroscanate Lopatol® C: 50.0 o. B base, C cat, D dog, d day, kg kilogram, mg milligram, o. orally Table A.3 Combination drugs against cestodes and nematodes of dogs and cats (selection) Dosage (mg/kg body Active compound Trade name weight) Application ® Fenbendazole (F) Caniquantel D/C: 50.0 (F) for 2–3 d + 5.0 o. + Praziquantel (P) Plus (P) ® Fenbantel + Praziquantel Drontal D: 15.0 + 5.0 + 5.0 o. pyrantelembonate Plus Pyrantelembonate Drontal® C: 20.0 + 5.0 o. + Praziquantel Pyrantelembonate + Oxantel Plerion® D: 25–50 (P), 100–200 (O), Chewable + Praziquantel 25–50 (PR) tablet Moxidectin + Imidacloprid (not Advocate® D: 2.5 + 10.0 Spot on against TW) C: 1.0 + 10.0 Emodepside + Praziquantel Profender® D: 10.0 + 50.0 D: o. C: 3.0 + 12.0 C: Spot on Milbemyxinoxim Milbemax® D/C: 0.5 + 5.0 o. + Praziquantel C cat, D dog, d day, kg kilogram, mg milligram, o. orally, TW tapeworms Table A.4 Antiparasitics acting against ectoparasites of dogs and cats (selection) Dosage/host Active (mg/kg body compound Trade name weight) Application Target group ® Fipronil Frontline D/C: 6.7 Spot-on Ticks, fleas, lice, Fipronil Frontline D/C:K:5+6 Cheyletiella mites + Methopren Combo® Imidacloprid Advantix® D: 10 + 50 Spot-on Ticks, fleas, sand + Permethrin flies, mosquitoes, lice Metaflumizon ProMeris D: 20 + 20 Spot-on Ticks, fleas + Amitraz Duo® Permethrin Exspot® D: 50 Spot-on Ticks, fleas, sand flies (continued) Addendum A: Antiparasitic Drugs Used for Animals 665 Table A.4 (continued) Dosage/host Active (mg/kg body compound Trade name weight) Application Target group Pyriprol Prac-tic® D: 12.5 Spot-on Ticks ® Selamectin Stronghold D/C: 6.0 Spot-on Fleas, sarcoptic mites ® Imidacloprid Advocate D: 10 + 2.5 Spot-on Sarcoptes, Demodex, + Moxidectin C: 10 + 1.0 Otodectes mites, lice, fleas Metaflumizon ProMeris® C: 40 Spot-on Fleas Imidacloprid Advantage® D/C: 10 Spot-on Fleas ® Permethrin Duowin D: 94 + 1 Spray Ticks + Pyriproxyfen Lufenuron Program® D:10 o. Fleas C:10 s.c. Nitenpyram Capstar® D/C: 1 o. Fleas ® Deltamethrin Scalibor D: neclace Neclace Fleas, sand flies, ticks Flumethrin Kiltix® D: neclace Neclace Fleas, ticks + Propoxur Imidacloprid Serestro® C: neclace Neclace Fleas + Flumethrin Margosa Vermin D/C: Washing: Single Ticks, mites, fleas, extract shampoo 50 ml shampoo washing lice, mallophages Wash Away® for small animals ® Margosa MiteStop D/C: dilute Dip into the Ticks, mites, fleas, extract Dog/cat extract 1:40 with diluted extract mallophages, tap water or wet the fur especially autumn mites Amitraz Ectodex® D: 0.05 % Bath every 7 d Skin mites Fenthion Tiguvon® C: 100 mg/ml Pour-on Fleas C cat, d dog, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.5 Anthelmintics of cattle for oral or pour-on application (selection) Active Trade Dosage (mg/kg Waiting time/days compound name body weight) Application (Germany) (Pro)Benzimidazole Febantel Rintal® 7.5 o. DA ¼ 2d;E¼ 14 d Fenbendazole Panacur® 7.5 o. DA ¼ 6d;E¼ 7d Albendazole Valbazen® 7.5 o. DA ¼ 5d;E¼ 28 d Neotobimin Hepadex® 7.5 o. DA ¼ 5; E ¼ 10 Oxfendazole Systamex® 4.5 o. DA ¼ 5; E ¼ 10 Macrocyclic lactones Doramectin Dectomax® 0.2 (0.5) s.c. (pour-on) NL: 50 (35) d Eprinomectin Eprinex® 0.5 Pour-on DA ¼ 0d;E¼ 30 d Ivermectin Ivomec® 0.2 (0.5) s.c. (pour-on) NL; E ¼ 28 (continued) 666 Addendum A: Antiparasitic Drugs Used for Animals Table A.5 (continued) Active Trade Dosage (mg/kg Waiting time/days compound name body weight) Application (Germany) Moxidectin Cydectin® 0.2 (0.5) s.c. (pour-on) DA ¼ 0d;E¼ 14 d (pour- on) resp. 65 d (s.c.) Imidazothiazole Levamisole Citarin® 7.5; 0.5; 10 p.o.; i.m.; NL; E ¼ 8 d; 8 d; 22 d pour-on d day, DA dairy animals, E edible tissue, i.m. intramuscularly, kg kilogram, mg milligram, NL not for lactating animals, o. orally, s.c. subcutaneously Table A.6 Anthelmintics for cattle as bolus against gastrointestinal strongylids Active Waiting Duration of compound Trade name Dosage time effect Oxfendazole Systamex Intervall- Every 23 d 1250 mg E ¼ 100 150 d (7.5 g) Bolus forte® each d, NL Fenbendazole Panacur-SR®-Bolus Daily 0.2–0.4 mg/kg E ¼ 100 Up to 140 d (12 g) body weight d, NL Levamisole Chronomintic®-Bolus (a) 2 g at the beginning E ¼ 140 Up to 90 d (18.8 g) (b) then 220 mg/d d, NL d days, E waiting time for edible tissues, g gram, mg milligram, NL not for lactating animals Table A.7 Nematocidal anthelmintics for sheep and goats (selection) Active Dosage (mg/kg Waiting time/days compound Trade name body weight) Application (Germany) (Pro)Benzimidazoles Mebendazole Ovitelmin® 15–20 o. DA ¼ 0d;E¼ 2d Fenbendazole Panacur® 5.0 o. DA ¼ 5d;E¼ 21 d Albendazole Valbazen®, 3.8 o. DA ¼ 5d;E¼ 10– Albazol® 14 d Febantel Rintal® 5.0 o. DA ¼ 2d;E¼ 14 d Netobimin Hepadex® 7.5 o. DA ¼ 5d;E¼ 5d Oxfendazole Systamex® 5.0 o. NL; E ¼ 14 d Macrocyclic lactones Doramectin Dectomax® 0.2 i.m. NL; E ¼ 70 d Ivermectin Ivomec®, 0.2 s.c. NL; E ¼ 42 d Virbamec® Eprinomectin Eprinex® 1.0 Pour-on DA ¼ 0; E ¼ 15 d Moxidectin Cydectin® 0.2 o. DA ¼ 5d;E¼ 14 d Imidazothiazole Levamisole Citarin® 8.0 s.c. NL; E ¼ 14 d Chronomintic® d day, DA dairy animal, E edible tissue, i.m. intramuscularly, kg kilogram, mg milligram, NL not for lactating animals, o. orally, s.c. subcutaneously Addendum A: Antiparasitic Drugs Used for Animals 667 Table A.8 Selection of remedies against ectoparasites of ruminants (check for approval for animal species and efficacy) Active Dosage (mg/kg body Waiting time/ compound Trade name weight) Application days Amitraz Taktic® 0.025 % Spray Spray 4 d Cyfluthrin Bayofly® 0.2 Pour-on 0 d Cyhalothrin Cyhalothrin® 0.2–0.4 Pour-on 0 d Cypermethrin Flectron- Earclip Attachment 0 d Earclip® Deltamethrin Butox® 0.75 Pour-on 18 d; DA ¼ 0d Flumethrin Bayticol® 2.0 Pour-on 5 d; DA ¼ 8d Doramectin Dectomex® 0.2–0.5 Pour-on 35 d; NL Ivermectin Ivomec® 0.2–0.5 Pour-on 28 d; NL Eprinomectin Eprinex® 0.5 Pour-on 15 d; DA ¼ 0d Moxidectin Cydectin® 0.5 Pour-on 14 d; DA ¼ 0d Phoxim Sebacil® Spray Spray 35 d; NL d day, DA dairy animal, kg kilogram, mg milligram, NL not for lactating animals Table A.9 Selection of remedies against ectoparasites of horses Active Trade Dosage (mg/kg body compound name weight) Application Parasite ® Ivermectin Ivomec P , 0.2 Orally Gasterophilus Eraquell® larvae ® Ivermectin Equimax , 0.2 + 1.5 Orally Gasterophilus + Praziquantel Eqvalan® larvae ® Moxidectin Equest 0.4 Orally Gasterophilus larvae Moxidectin Equest 0.4 + 2.5 Orally Gasterophilus + Praziquantel Pramox® larvae Permethrin Wellcare® 4.2 Application Flies, gadflies Emulsion on the fur every 14 d Neem Seed TaonX® Spray until fur is Spray Gadflies, flies, Extract moistened midges, black flies, + Saltidin mosquitoes, ticks, mites Neem Seed MiteStop® Dilution of 100 ml Brush or Ticks, mites, Extract Horse extract in 2 l of H2O sponge mallophages, + Margosa and application on the gadflies, flies, fur with a brush or midges, black flies, sponge mosquitoes d day, kg kilogram, mg milligram 668 Addendum A: Antiparasitic Drugs Used for Animals Table A.10 Anthelmintics for horses against nematodes Dosage (mg/kg Waiting time/ Active compound Trade name body weight) Application days (Germany) (Pro)Benzimidazoles Febantel Rintal® 6.0 Orally E ¼ 20 d; NL Febantel Rintal® Plus + Metrifonate Fenbendazole Panacur®, 10.0 Orally E ¼ 7d;NL Equivermex® Mebendazole Telmin®, 10.0 Orally E ¼ 7d;NL Mebendazole Telmin® Plus + Metrifonat Oxibendazole Equitac® 10.0 Orally E ¼ 8d Macrocyclic lactones Ivermectin Ivomec®, 0.2 Orally E ¼ 21 d; NL Eqvalan®, Equell® Moxidectin Equest® 0.4 Orally E ¼ 32 d; NL Pyrimidine Pyrantelembonate Banminth®, 6.6 Orally E ¼ 1d;NL Strongid-P® d day, E edible tissues, kg kilogram, mg milligram, NL not for lactating animals, o.
Load more

Recommended publications
  • Drontal Nematocide and Cestocide for Cats
    28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 1 Drontal Nematocide and Cestocide for cats Product information International Edition 28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 2 Bayer AG Business Group Animal Health D-51368 Leverkusen Germany 2 28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 3 Drontal Important note This product information on Drontal is based on the available results of controlled inter- national studies. User information is to be found in the instructions for use contained in the Drontal package inserts which have been approved by the regulatory authority. 3 28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 4 4 28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 5 Drontal Contents General Observations 6 The worm problem in cats 7 Roundworms (Nematodes) 7 Tapeworms (Cestodes) 8 Routes of infection 9 Oral infection 9 Percutaneous infection 10 Transmammary infection (post partum) 10 Damage to health in cats 11 Clinical manifestations 12 Routes of infection in man (false host) 13 Oral infection 13 Percutaneous 14 Damage to human health (man as false host) 15 Life cycle of the most important intestinal worms of the cat 18 1. Nematodes 18 2. Cestodes 21 Control of worm infections in cats 24 Diagnosis and prepatent periods 24 Treatment programmes 24 Drontal Product Profile 27 1. Active ingredients 27 2. Mode of action 28 3. Spectrum of activity/Indications 28 4. Dosage 28 5. Efficacy 29 6. Tolerability 32 References 33 5 28400 Aufbau neu 09.07.2003 13:27 Uhr Seite 6 Drontal General observations Worm infections continue to be a major problem in farm livestock and companion animals worldwide, as well as in man.
    [Show full text]
  • Viral Haemorrhagic Septicaemia Virus (VHSV): on the Search for Determinants Important for Virulence in Rainbow Trout Oncorhynchus Mykiss
    Downloaded from orbit.dtu.dk on: Nov 08, 2017 Viral haemorrhagic septicaemia virus (VHSV): on the search for determinants important for virulence in rainbow trout oncorhynchus mykiss Olesen, Niels Jørgen; Skall, H. F.; Kurita, J.; Mori, K.; Ito, T. Published in: 17th International Conference on Diseases of Fish And Shellfish Publication date: 2015 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Olesen, N. J., Skall, H. F., Kurita, J., Mori, K., & Ito, T. (2015). Viral haemorrhagic septicaemia virus (VHSV): on the search for determinants important for virulence in rainbow trout oncorhynchus mykiss. In 17th International Conference on Diseases of Fish And Shellfish: Abstract book (pp. 147-147). [O-139] Las Palmas: European Association of Fish Pathologists. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. DISCLAIMER: The organizer takes no responsibility for any of the content stated in the abstracts.
    [Show full text]
  • New Zealand's Genetic Diversity
    1.13 NEW ZEALAND’S GENETIC DIVERSITY NEW ZEALAND’S GENETIC DIVERSITY Dennis P. Gordon National Institute of Water and Atmospheric Research, Private Bag 14901, Kilbirnie, Wellington 6022, New Zealand ABSTRACT: The known genetic diversity represented by the New Zealand biota is reviewed and summarised, largely based on a recently published New Zealand inventory of biodiversity. All kingdoms and eukaryote phyla are covered, updated to refl ect the latest phylogenetic view of Eukaryota. The total known biota comprises a nominal 57 406 species (c. 48 640 described). Subtraction of the 4889 naturalised-alien species gives a biota of 52 517 native species. A minimum (the status of a number of the unnamed species is uncertain) of 27 380 (52%) of these species are endemic (cf. 26% for Fungi, 38% for all marine species, 46% for marine Animalia, 68% for all Animalia, 78% for vascular plants and 91% for terrestrial Animalia). In passing, examples are given both of the roles of the major taxa in providing ecosystem services and of the use of genetic resources in the New Zealand economy. Key words: Animalia, Chromista, freshwater, Fungi, genetic diversity, marine, New Zealand, Prokaryota, Protozoa, terrestrial. INTRODUCTION Article 10b of the CBD calls for signatories to ‘Adopt The original brief for this chapter was to review New Zealand’s measures relating to the use of biological resources [i.e. genetic genetic resources. The OECD defi nition of genetic resources resources] to avoid or minimize adverse impacts on biological is ‘genetic material of plants, animals or micro-organisms of diversity [e.g. genetic diversity]’ (my parentheses).
    [Show full text]
  • Multiyear Survey of Coccidia, Cryptosporidia, Microsporidia, Histomona, and Hematozoa in Wild Quail in the Rolling Plains Ecoregion of Texas and Oklahoma, USA
    Journal of Eukaryotic Microbiology ISSN 1066-5234 ORIGINAL ARTICLE Multiyear Survey of Coccidia, Cryptosporidia, Microsporidia, Histomona, and Hematozoa in Wild Quail in the Rolling Plains Ecoregion of Texas and Oklahoma, USA Lixin Xianga,b, Fengguang Guob, Yonglan Yuc, Lacy S. Parsonb, Lloyd LaCosted, Anna Gibsone, Steve M. Presleye, Markus Petersonf, Thomas M. Craigb, Dale Rollinsd,f, Alan M. Fedynichg & Guan Zhub a College of Life Science, Zhejiang University, Hangzhou, Zhejiang 310058, China b Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas 77843-4467, USA c College of Veterinary Medicine, China Agricultural University, Haidian District, Beijing 100193, China d Rolling Plains Quail Research Foundation, San Angelo, Texas 76901, USA e Institute of Environmental & Human Health, Texas Tech University, Lubbock, Texas 79416, USA f Department of Wildlife & Fisheries Sciences, Texas A&M University, College Station, Texas 77843-2258, USA g Caesar Kleberg Wildlife Research Institute, Texas A&M University-Kingsville, Kingsville, Texas 78363, USA Keywords ABSTRACT Cryptosporidium; molecular epidemiology; northern bobwhite (Colinus virginianus); pro- We developed nested PCR protocols and performed a multiyear survey on the tozoan parasites; scaled quail (Callipepla prevalence of several protozoan parasites in wild northern bobwhite (Colinus squamata). virginianus) and scaled quail (Callipepla squamata) in the Rolling Plains ecore- gion of Texas and Oklahoma (i.e. fecal pellets, bird intestines and blood Correspondence smears collected between 2010 and 2013). Coccidia, cryptosporidia, and G. Zhu, Department of Veterinary Pathobiol- microsporidia were detected in 46.2%, 11.7%, and 44.0% of the samples ogy, College of Veterinary Medicine & (n = 687), whereas histomona and hematozoa were undetected.
    [Show full text]
  • Journal of Parasitology
    Journal of Parasitology Eimeria taggarti n. sp., a Novel Coccidian (Apicomplexa: Eimeriorina) in the Prostate of an Antechinus flavipes --Manuscript Draft-- Manuscript Number: 17-111R1 Full Title: Eimeria taggarti n. sp., a Novel Coccidian (Apicomplexa: Eimeriorina) in the Prostate of an Antechinus flavipes Short Title: Eimeria taggarti n. sp. in Prostate of Antechinus flavipes Article Type: Regular Article Corresponding Author: Jemima Amery-Gale, BVSc(Hons), BAnSci, MVSc University of Melbourne Melbourne, Victoria AUSTRALIA Corresponding Author Secondary Information: Corresponding Author's Institution: University of Melbourne Corresponding Author's Secondary Institution: First Author: Jemima Amery-Gale, BVSc(Hons), BAnSci, MVSc First Author Secondary Information: Order of Authors: Jemima Amery-Gale, BVSc(Hons), BAnSci, MVSc Joanne Maree Devlin, BVSc(Hons), MVPHMgt, PhD Liliana Tatarczuch David Augustine Taggart David J Schultz Jenny A Charles Ian Beveridge Order of Authors Secondary Information: Abstract: A novel coccidian species was discovered in the prostate of an Antechinus flavipes (yellow-footed antechinus) in South Australia, during the period of post-mating male antechinus immunosuppression and mortality. This novel coccidian is unusual because it develops extra-intestinally and sporulates endogenously within the prostate gland of its mammalian host. Histological examination of prostatic tissue revealed dense aggregations of spherical and thin-walled tetrasporocystic, dizoic sporulated coccidian oocysts within tubular lumina, with unsporulated oocysts and gamogonic stages within the cytoplasm of glandular epithelial cells. This coccidian was observed occurring concurrently with dasyurid herpesvirus 1 infection of the antechinus' prostate. Eimeria- specific 18S small subunit ribosomal DNA PCR amplification was used to obtain a partial 18S rDNA nucleotide sequence from the antechinus coccidian.
    [Show full text]
  • Arthropod Parasites in Domestic Animals
    ARTHROPOD PARASITES IN DOMESTIC ANIMALS Abbreviations KINGDOM PHYLUM CLASS ORDER CODE Metazoa Arthropoda Insecta Siphonaptera INS:Sip Mallophaga INS:Mal Anoplura INS:Ano Diptera INS:Dip Arachnida Ixodida ARA:Ixo Mesostigmata ARA:Mes Prostigmata ARA:Pro Astigmata ARA:Ast Crustacea Pentastomata CRU:Pen References Ashford, R.W. & Crewe, W. 2003. The parasites of Homo sapiens: an annotated checklist of the protozoa, helminths and arthropods for which we are home. Taylor & Francis. Taylor, M.A., Coop, R.L. & Wall, R.L. 2007. Veterinary Parasitology. 3rd edition, Blackwell Pub. HOST-PARASITE CHECKLIST Class: MAMMALIA [mammals] Subclass: EUTHERIA [placental mammals] Order: PRIMATES [prosimians and simians] Suborder: SIMIAE [monkeys, apes, man] Family: HOMINIDAE [man] Homo sapiens Linnaeus, 1758 [man] ARA:Ast Sarcoptes bovis, ectoparasite (‘milker’s itch’)(mange mite) ARA:Ast Sarcoptes equi, ectoparasite (‘cavalryman’s itch’)(mange mite) ARA:Ast Sarcoptes scabiei, skin (mange mite) ARA:Ixo Ixodes cornuatus, ectoparasite (scrub tick) ARA:Ixo Ixodes holocyclus, ectoparasite (scrub tick, paralysis tick) ARA:Ixo Ornithodoros gurneyi, ectoparasite (kangaroo tick) ARA:Pro Cheyletiella blakei, ectoparasite (mite) ARA:Pro Cheyletiella parasitivorax, ectoparasite (rabbit fur mite) ARA:Pro Demodex brevis, sebacceous glands (mange mite) ARA:Pro Demodex folliculorum, hair follicles (mange mite) ARA:Pro Trombicula sarcina, ectoparasite (black soil itch mite) INS:Ano Pediculus capitis, ectoparasite (head louse) INS:Ano Pediculus humanus, ectoparasite (body
    [Show full text]
  • Worms, Nematoda
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications from the Harold W. Manter Laboratory of Parasitology Parasitology, Harold W. Manter Laboratory of 2001 Worms, Nematoda Scott Lyell Gardner University of Nebraska - Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/parasitologyfacpubs Part of the Parasitology Commons Gardner, Scott Lyell, "Worms, Nematoda" (2001). Faculty Publications from the Harold W. Manter Laboratory of Parasitology. 78. https://digitalcommons.unl.edu/parasitologyfacpubs/78 This Article is brought to you for free and open access by the Parasitology, Harold W. Manter Laboratory of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications from the Harold W. Manter Laboratory of Parasitology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Published in Encyclopedia of Biodiversity, Volume 5 (2001): 843-862. Copyright 2001, Academic Press. Used by permission. Worms, Nematoda Scott L. Gardner University of Nebraska, Lincoln I. What Is a Nematode? Diversity in Morphology pods (see epidermis), and various other inverte- II. The Ubiquitous Nature of Nematodes brates. III. Diversity of Habitats and Distribution stichosome A longitudinal series of cells (sticho- IV. How Do Nematodes Affect the Biosphere? cytes) that form the anterior esophageal glands Tri- V. How Many Species of Nemata? churis. VI. Molecular Diversity in the Nemata VII. Relationships to Other Animal Groups stoma The buccal cavity, just posterior to the oval VIII. Future Knowledge of Nematodes opening or mouth; usually includes the anterior end of the esophagus (pharynx). GLOSSARY pseudocoelom A body cavity not lined with a me- anhydrobiosis A state of dormancy in various in- sodermal epithelium.
    [Show full text]
  • Parasite Kit Description List (PDF)
    PARASITE KIT DESCRIPTION PARASITES 1. Acanthamoeba 39. Diphyllobothrium 77. Isospora 115. Pneumocystis 2. Acanthocephala 40. Dipylidium 78. Isthmiophora 116. Procerovum 3. Acanthoparyphium 41. Dirofilaria 79. Leishmania 117. Prosthodendrium 4. Amoeba 42. Dracunculus 80. Linguatula 118. Pseudoterranova 5. Ancylostoma 43. Echinochasmus 81. Loa Loa 119. Pygidiopsis 6. Angiostrongylus 44. Echinococcus 82. Mansonella 120. Raillietina 7. Anisakis 45. Echinoparyphium 83. Mesocestoides 121. Retortamonas 8. Armillifer 46. Echinostoma 84. Metagonimus 122. Sappinia 9. Artyfechinostomum 47. Eimeria 85. Metastrongylus 123. Sarcocystis 10. Ascaris 48. Encephalitozoon 86. Microphallus 124. Schistosoma 11. Babesia 49. Endolimax 87. Microsporidia 1 125. Spirometra 12. Balamuthia 50. Entamoeba 88. Microsporidia 2 126. Stellantchasmus 13. Balantidium 51. Enterobius 89. Multiceps 127. Stephanurus 14. Baylisascaris 52. Enteromonas 90. Naegleria 128. Stictodora 15. Bertiella 53. Episthmium 91. Nanophyetus 129. Strongyloides 16. Besnoitia 54. Euparyphium 92. Necator 130. Syngamus 17. Blastocystis 55. Eustrongylides 93. Neodiplostomum 131. Taenia 18. Brugia.M 56. Fasciola 94. Neoparamoeba 132. Ternidens 19. Brugia.T 57. Fascioloides 95. Neospora 133. Theileria 20. Capillaria 58. Fasciolopsis 96. Nosema 134. Thelazia 21. Centrocestus 59. Fischoederius 97. Oesophagostmum 135. Toxocara 22. Chilomastix 60. Gastrodiscoides 98. Onchocerca 136. Toxoplasma 23. Clinostomum 61. Gastrothylax 99. Opisthorchis 137. Trachipleistophora 24. Clonorchis 62. Giardia 100. Orientobilharzia 138. Trichinella 25. Cochliopodium 63. Gnathostoma 101. Paragonimus 139. Trichobilharzia 26. Contracaecum 64. Gongylonema 102. Passalurus 140. Trichomonas 27. Cotylurus 65. Gryodactylus 103. Pentatrichormonas 141. Trichostrongylus 28. Cryptosporidium 66. Gymnophalloides 104. Pfiesteria 142. Trichuris 29. Cutaneous l.migrans 67. Haemochus 105. Phagicola 143. Tritrichomonas 30. Cyclocoelinae 68. Haemoproteus 106. Phaneropsolus 144. Trypanosoma 31. Cyclospora 69. Hammondia 107. Phocanema 145. Uncinaria 32.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • An Intestinal Gregarine of Nothria Conchylega (Polychaeta, Onuphidae)
    Journal of Invertebrate Pathology 104 (2010) 172–179 Contents lists available at ScienceDirect Journal of Invertebrate Pathology journal homepage: www.elsevier.com/locate/jip Description of Trichotokara nothriae n. gen. et sp. (Apicomplexa, Lecudinidae) – An intestinal gregarine of Nothria conchylega (Polychaeta, Onuphidae) Sonja Rueckert *, Brian S. Leander Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity, Departments of Botany and Zoology, University of British Columbia, #3529 – 6270 University Blvd., Vancouver, BC, Canada V6T 1Z4 article info abstract Article history: The trophozoites of a novel gregarine apicomplexan, Trichotokara nothriae n. gen. et sp., were isolated and Received 12 November 2009 characterized from the intestines of the onuphid tubeworm Nothria conchylega (Polychaeta), collected at Accepted 11 March 2010 20 m depth from the North-eastern Pacific Coast. The trophozoites were 50–155 lm long with a mid-cell Available online 23 March 2010 indentation that formed two prominent bulges (anterior bulge, 14–48 lm wide; posterior bulge, 15– 55 lm wide). Scanning electron microscopy (SEM) demonstrated that approximately 400 densely packed, Keywords: longitudinal epicytic folds (5 folds/lm) inscribe the surface of the trophozoites, and a prominently elon- Alveolata gated mucron (14–60 lm long and 6–12 lm wide) was covered with hair-like projections (mean length, Apicomplexa 1.97 m; mean width, 0.2 m at the base). Although a septum occurred at the junction between the cell Lecudinidae l l Lecudina proper and the mucron in most trophozoites, light microscopy (LM) demonstrated that the cell proper Parasite extended into the core of the mucron as a thin prolongation.
    [Show full text]
  • An Evaluation of Eprinomectin Extended-Release Injectable (Longrange®) on the Performance of Yearling Cattle on Pasture in Western Canada
    PEER REVIEWED © Copyright American Association American© Copyright ofBovine Practitioners; open access distribution. An evaluation of eprinomectin extended-release injectable (LongRange®) on the performance of yearling cattle on pasture in western Canada Ryan D. Rademacher, BSc, DVM; Eric J. Behlke, BSc, MSc, PhD, DVM; Sandi L. Parr, BSc, MSc, PhD; Sherry J. Hannon, DVM, MVetSc, PhD; Christina M. Williams, BSc, MSc; R. Kent Fenton, DVM; G. Kee Jim, DVM; Calvin W. Booker, DVM, MVetSc Feedlot Health Management Services Ltd., PO Box 140, Okotoks, Alberta, Canada T1S 2A2 Corresponding author: Dr. Calvin Booker; Tel: (403) 938-5151; Fax: (403) 938-5175; [email protected] Abstract sous forme injectable a la dose de 0.45 mg/lb (1.0 mg/kg) d'unite de poids corporel (PC) dans la partie lache de la peau During the pre-shipment handling procedures at each devant l'epaule. Les animaux dans le groupe IVER (1524 ani­ of 2 feedlots of origin, mixed-breed beef steers were weighed, maux) ont re<;u a l'allocation une application d'ivermectine sur stratified into weight blocks, and simultaneously randomized le long de la ligne superieure du garrot jusqu’a l’attache de la within weight block to 1 of 2 experimental groups (LONG or queue a la dose de 0.23 mg/lb (0.5 mg/kg) d’unite de PC. Apres IVER) prior to shipment to pasture. Animals in the LONG l’allocation, les animaux des deux groupes experimentaux ont group (1523 animals) received a subcutaneous injection of ete amalgames a l'interieur de chaque bloc de poids et selon le eprinomectin extended-release injectable at a dosage of 0.45 pare d'alimentation d’origine et sont restes dans ces groupes mg/lb (1.0 mg/kg) body weight (BW) in the loose skin in front amalgames pendant toute la duree de l’etude.
    [Show full text]
  • Clinical Cysticercosis: Diagnosis and Treatment 11 2
    WHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniosis/cysticercosis Editor: K.D. Murrell Associate Editors: P. Dorny A. Flisser S. Geerts N.C. Kyvsgaard D.P. McManus T.E. Nash Z.S. Pawlowski • Etiology • Taeniosis in humans • Cysticercosis in animals and humans • Biology and systematics • Epidemiology and geographical distribution • Diagnosis and treatment in humans • Detection in cattle and swine • Surveillance • Prevention • Control • Methods All OIE (World Organisation for Animal Health) publications are protected by international copyright law. Extracts may be copied, reproduced, translated, adapted or published in journals, documents, books, electronic media and any other medium destined for the public, for information, educational or commercial purposes, provided prior written permission has been granted by the OIE. The designations and denominations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the OIE concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries. The views expressed in signed articles are solely the responsibility of the authors. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by the OIE in preference to others of a similar nature that are not mentioned. –––––––––– The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations, the World Health Organization or the World Organisation for Animal Health concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]